MARKET

HROW

HROW

Harrow Health Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.15
-0.17
-2.69%
Closed 16:00 08/13 EDT
OPEN
6.32
PREV CLOSE
6.32
HIGH
6.33
LOW
6.05
VOLUME
85.80K
TURNOVER
--
52 WEEK HIGH
7.92
52 WEEK LOW
3.330
MARKET CAP
157.75M
P/E (TTM)
-6.4486
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average HROW stock price target is 10.75 with a high estimate of 11.50 and a low estimate of 10.00.

EPS

HROW News

More
Harrow Health (HROW) Reports Q2 Loss, Tops Revenue Estimates
Zacks · 2d ago
Harrow Health, Inc. (HROW) CEO Mark Baum on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 2d ago
Harrow Health Publishes Second Quarter 2020 Letter to Stockholders
GlobeNewswire · 3d ago
Harrow Health's Earnings Outlook
Benzinga · 6d ago
EyePoint Pharmaceuticals and Harrow Healths ImprimisRx Announce U.S. Commercial Alliance for DEXYCU®
GlobeNewswire · 08/04 12:00
EyePoint Pharmaceuticals And Harrow Health's ImprimisRx Announce U.S. Commercial Alliance For DEXYCU
Benzinga · 08/04 11:46
EyePoint Pharmaceuticals And Harrow Health's ImprimisRx Announce US Commercial Alliance For DEXYCU
WATERTOWN, Mass. and NASHVILLE, Tenn., Aug. 04, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc.(NASDAQ:EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products,
Benzinga · 08/04 11:13
Analysts Estimate Harrow Health (HROW) to Report a Decline in Earnings: What to Look Out for
Zacks · 08/03 17:31

Industry

Biotechnology & Medical Research
+1.09%
Pharmaceuticals & Medical Research
-0.01%

Hot Stocks

Symbol
Price
%Change

About HROW

Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., owns diversified portfolio of healthcare businesses. The Company’s subsidiaries are Imprimis Pharmaceuticals Inc. and Park Compounding. Imprimis Pharmaceuticals Inc. is engaged in ophthalmology pharmaceutical compounding business. Park Compounding is engaged in compounding business and also offers strategic research and development facilities, which is engaged in developing and dispensing medicines for individual patients.
More

Webull offers kinds of Harrow Health Inc stock information, including NASDAQ:HROW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HROW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HROW stock methods without spending real money on the virtual paper trading platform.